Status:
COMPLETED
A Multiple Ascending Dose Study of RO4998452 in Patients With Type 2 Diabetes Mellitus.
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Diabetes Mellitus Type 2
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
This study will evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple ascending doses of RO4998452 compared to placebo in patients with type 2 diabetes mellitus. Success...
Eligibility Criteria
Inclusion
- adult patients, 18-65 years of age;
- type 2 diabetes;
- either treated by diet and exercise alone or with metformin.
Exclusion
- type 1 diabetes mellitus;
- uncontrolled hypertension;
- clinically severe diabetic complications.
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT00682097
Start Date
May 1 2008
End Date
March 1 2009
Last Update
November 2 2016
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Chula Vista, California, United States, 91911
2
San Antonio, Texas, United States, 78229
3
Neuss, Germany, 41460